Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERGJustin M. Roberts, Nancy L. Weigel, Danthasinghe Waduge Badrajee Piyarathna et al.|Oncotarget|2017Cited by 2